To investigate the reason, the authors found that high levels of NEIL3 expression were positively correlated with high levels of the mutation inducer (APOBEC3B) in 10 of the 13 cancers (76.9%), which may explain the increased number of somatic mutations induced by NEIL3 overexpression in cancer [62]. The gene discussed is APOBEC3B; the disease is cancer.